<SEC-DOCUMENT>0000902664-25-004764.txt : 20251106
<SEC-HEADER>0000902664-25-004764.hdr.sgml : 20251106
<ACCEPTANCE-DATETIME>20251106194602
ACCESSION NUMBER:		0000902664-25-004764
CONFORMED SUBMISSION TYPE:	144/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251106
DATE AS OF CHANGE:		20251106

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		251460074

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3
		BUSINESS PHONE:		972 (3) 914-8213

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRIDGER MANAGEMENT, LLC
		CENTRAL INDEX KEY:			0001166309
		ORGANIZATION NAME:           	
		EIN:				582553507
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144/A

	BUSINESS ADDRESS:	
		STREET 1:		90 PARK AVENUE, 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		212-918-0820

	MAIL ADDRESS:	
		STREET 1:		90 PARK AVENUE, 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRIDGER MANAGEMENT LLC
		DATE OF NAME CHANGE:	20020130
</SEC-HEADER>
<DOCUMENT>
<TYPE>144/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144/A</submissionType>
    <previousAccessionNumber>0000902664-25-004073</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: BRIDGER MANAGEMENT, LLC -->
          <cik>0001166309</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000818686</issuerCik>
      <issuerName>Teva Pharmaceutical Industries Limited</issuerName>
      <secFileNumber>001-16174</secFileNumber>
      <issuerAddress>
        <com:street1>124 Dvora HaNevi'a St</com:street1>
        <com:city>Tel Aviv</com:city>
        <com:stateOrCountry>L3</com:stateOrCountry>
        <com:zipCode>6944020</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972-3-914-8213</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Bridger Management, LLC (1)</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Shareholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>American Depositary Shares(2)</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Piper Sandler &amp; Co.</name>
        <address>
          <com:street1>1 Greenwich Plaza</com:street1>
          <com:city>Greenwich</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06830</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>200000</noOfUnitsSold>
      <aggregateMarketValue>4920000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>1147282512</noOfUnitsOutstanding>
      <approxSaleDate>11/06/2025</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>American Depositary Shares</securitiesClassTitle>
      <acquiredDate>05/09/2018</acquiredDate>
      <natureOfAcquisitionTransaction>See Remark 3</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>See Remark 3</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>200000</amountOfSecuritiesAcquired>
      <paymentDate>05/09/2018</paymentDate>
      <natureOfPayment>See Remark 3</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>(1) Bridger Management, LLC ("Bridger") serves as the investment manager of Swiftcurrent Master Fund, Ltd., which holds the American Depositary Shares ("ADSs") representing Ordinary Shares covered by this Form 144. Roberto Mignone, Founder and Managing Partner of Bridger, is a member of the board of directors of the Issuer. (2) This Form 144/A amends and restates the Form 144 filed on September 12, 2025 to increase the number of ADRs to be sold. No ADRs listed on the September 12, 2025 Form 144 were previously sold. (3) The ADSs reported herein to be sold were originally acquired through open market purchases on dates ranging from May 9, 2018 to May 10, 2018.</remarks>
    <noticeSignature>
      <noticeDate>11/06/2025</noticeDate>
      <signature>Bridger Management, LLC, By: /s/ Matthew P. Truax, Chief Operating Officer, General Counsel and Chief Compliance Officer</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
